Industry News Roundup
This article was originally published in The Tan Sheet
Pharmavite annexes FoodState; CSPI urges ban on caffeine powder; NCCIH debuts at NIH; Gravity in Hantain’s orbit; SDC Nutrition in Costa Rica, Cayman Islands; Mannatech in Spain; and Food Advisory Committee nominations.
You may also be interested in...
FDAs Oct. 3 meeting agenda includes Pieter Cohen, Harvard Medical School professor; Consumers Union Programs Director Chuck Bell; Laura MacCleery, Center for Science in the Public Interest regulatory affairs director; and Stephanie Scarmo, Pew Charitable Trusts Health Care Products Project officer.
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.